Best Dermatology Journals (2026): Ranked by Impact and Accessibility
Ranked list of the top 12 dermatology journals by scope fit, selectivity, APC, and review speed, covering clinical, investigative, surgical, and open-access dermatology outlets.
Readiness scan
Which dermatology journal fits your draft?
Run the Free Readiness Scan with your draft to see fit, framing, and desk-reject risk against the leading dermatology venues.
Quick answer: The best dermatology journal depends on whether the manuscript is clinical, investigative, surgical, image-heavy, disease-specific, or open-access. Use JAMA Dermatology or JAAD for practice-facing clinical work, JID for skin biology and translational mechanism, BJD or JEADV for strong international clinical studies, Dermatologic Surgery for procedural work, and JAAD International, JID Innovations, Acta Dermato-Venereologica, or Clinical and Experimental Dermatology when accessibility or fit matters more than selectivity.
Best Dermatology Journals By Manuscript Type
- JAMA Dermatology (IF ~10.9) for high-impact clinical research
- Journal of the American Academy of Dermatology (JAAD) (IF ~11.5) for clinical dermatology
- Journal of Investigative Dermatology (JID) (IF ~5.7) for basic and translational research
- British Journal of Dermatology (BJD) (IF ~9.6) for international clinical research
- Journal of the European Academy of Dermatology (JEADV) (IF ~8.0) for European clinical work
Before picking from the dermatology journals below, run a dermatology manuscript fit check to see whether your draft is closer to a top-tier or accessible-tier target before you commit to a submission.
For an exact current metric lookup for American Journal of Clinical Dermatology, see the dedicated American Journal of Clinical Dermatology impact factor page. This guide remains the owner for broad dermatology-journal selection.
Dermatology Journal Fit Table
Journal | Best for | Accessibility signal | Check before submitting |
|---|---|---|---|
JAMA Dermatology | Practice-changing clinical trials, cohorts, reviews, and policy work | Highly selective, JAMA-network reach | The clinical implication should matter beyond one dermatology clinic |
JAAD | Broad clinical dermatology, guidelines, reviews, images, and clinician-facing work | Selective, AAD readership | The paper should offer something practicing dermatologists can use |
JID | Skin biology, genetics, immunology, wound healing, and translational mechanism | Research-focused | Avoid it for purely clinical or observational studies |
British Journal of Dermatology | International clinical and translational dermatology | Fully OA route now matters | Confirm APC and OA funding before upload |
JEADV | European clinical dermatology, venereology, and guideline-relevant studies | Strong clinical readership | Best when the European or international clinical audience is natural |
Dermatologic Surgery | Mohs, lasers, procedures, cosmetic, and surgical outcomes | Procedural specialist audience | Use when technique and outcomes are the core contribution |
Accessible And Specialist Dermatology Routes
Journal | Best for | Why it can beat a flagship |
|---|---|---|
JAAD International | Open-access clinical dermatology | JAAD brand plus OA visibility for solid clinical work |
JID Innovations | Translational and basic skin science | Cleaner fit when the mechanism is sound but not JID-level |
Acta Dermato-Venereologica | Clinical and translational work needing low-cost OA | Indexed, reputable, and unusually affordable |
Clinical and Experimental Dermatology | Case series, smaller clinical studies, and educational reviews | Realistic target for useful but narrower clinical work |
Dermatology | Mid-range clinical and translational studies | European clinical readership without flagship selectivity |
Experimental Dermatology | Skin biology and mechanistic work | Better for basic science than a clinician-first journal |
Submission Details To Verify Before Upload
Route | Concrete check | Why it matters |
|---|---|---|
American Journal of Clinical Dermatology | Springer links the journal to Editorial Manager and lists article-type word limits such as original research normally up to 6,000 words | Clinical-review and therapy papers need the right article type before metrics matter |
British Journal of Dermatology | Confirm the current APC and OA funding route before upload | The fully open-access route can change the practical target even when the scope fits |
JAAD / JAAD International | Check current author guidelines for image, patient-consent, and clinical-photo requirements | Dermatology papers can fail on visual evidence quality before the clinical point is tested |
JID / JID Innovations | Confirm whether the paper is original research, translational, or mechanism-led before selecting the portal route | Skin-biology work needs a different reviewer pool than clinician-facing dermatology |
JAMA Dermatology
Part of the JAMA network, this journal carries enormous prestige and cross-specialty visibility. It publishes clinical trials, large cohort studies, systematic reviews, and health policy research related to skin disease. The editorial process is rigorous, and they're strict about study design and statistical methods. JAMA Dermatology is where practice-changing dermatology research gets published. If your paper has the potential to alter clinical guidelines, start here.
Journal of the American Academy of Dermatology (JAAD)
JAAD is the most widely read dermatology journal in the US. It covers everything from clinical reviews and guidelines to original research and continuing medical education. The journal has a strong clinical orientation and values practical relevance for practicing dermatologists. Your paper doesn't need to be the next landmark trial, but it does need to offer something a clinician can use. JAAD also publishes excellent clinical images and case series that other top journals ignore.
British Journal of Dermatology (BJD)
BJD recently transitioned to fully open access under Wiley, which has changed its dynamics. It remains one of the strongest dermatology journals globally, with a balanced mix of clinical and translational content. The journal has an international author base and doesn't lean as heavily toward UK-specific healthcare issues as you might expect. It's a strong alternative to JAAD for clinical research with good study design.
Journal of Investigative Dermatology (JID)
JID is the premier venue for basic and translational skin science. If your work involves keratinocyte biology, skin immunology, wound healing mechanisms, or genetic skin diseases, JID is the target. It doesn't publish clinical trials or purely observational studies. The review process values mechanistic depth and experimental rigor. This is a researcher's journal, not a clinician's journal.
JEADV
The Journal of the European Academy of Dermatology and Venereology is the primary European clinical dermatology journal outside of BJD. It publishes clinical studies, reviews, and guidelines with a European perspective. The acceptance rate around 20% makes it more realistic than JAAD or BJD, and the readership is large. It's a strong fit for clinical observational studies and guideline-relevant research.
Experimental Dermatology
This journal focuses on basic science in skin biology. It's more accessible than JID but maintains solid peer review standards. If your basic science paper doesn't quite reach JID's novelty threshold, Experimental Dermatology is a natural next choice. It values well-designed experiments and clear mechanistic conclusions.
Acta Dermato-Venereologica
Acta DV deserves special mention for offering free open access publishing. That's increasingly rare and extremely valuable. The journal is well-indexed, has a stable impact factor, and publishes quality clinical and translational work. It has Scandinavian roots but accepts international submissions. If you want OA without paying thousands in APCs, this is a top option.
Dermatologic Surgery
The go-to journal for procedural dermatology, including Mohs surgery, laser treatments, cosmetic procedures, and surgical techniques. If your research involves surgical outcomes, technique comparisons, or procedural innovations, this is the right home. General dermatology journals won't give procedural work the same attention.
JAAD International
JAAD's open access companion has grown quickly and now publishes a steady stream of clinical research. It's not a dump for JAAD rejects. It has its own editorial board and review process. The APC is reasonable, and the JAAD brand gives it immediate recognition. Good for well-designed clinical studies that need OA dissemination.
JID Innovations
JID's open access counterpart focuses on translational and basic research. It launched with the goal of publishing scientifically sound work that doesn't necessarily reach JID's impact threshold. It's a natural fallback after JID rejection and a reasonable first-choice for early-career researchers in skin biology.
Clinical and Experimental Dermatology
CED is an accessible option for case reports, small clinical studies, and educational reviews. The acceptance rate is forgiving, and the journal serves as a good training ground for junior researchers. It's indexed in all major databases, and publications here are counted in academic promotion portfolios.
Dermatology
This Basel-based journal publishes a mix of clinical studies and translational work with a European flavor. It's competitive but not impossibly so, and the editorial team is responsive. A good target for mid-range clinical research.
Decision Framework: Choosing Your Target
If your paper is a large clinical trial or cohort study, JAMA Dermatology or BJD should be your first choice. Both prioritize evidence-based clinical research.
If your paper is a clinical review or guideline, JAAD is the best fit. It's the journal practicing dermatologists actually read for clinical guidance.
If your paper is basic science (cell biology, genetics, immunology), JID is the target. For work that doesn't quite reach JID, try Experimental Dermatology.
If your paper is a surgical or procedural study, Dermatologic Surgery is the obvious and best choice.
If your paper needs open access on a budget, Acta Dermato-Venereologica offers free OA. JAAD International and JID Innovations have moderate APCs.
If your paper is a case series or small observational study, Clinical and Experimental Dermatology or JAAD International are realistic targets.
Readiness check
Find out what this manuscript actually needs before you choose a service.
Run the free scan to see whether the issue is scientific readiness, journal fit, or citation support before paying for more help.
Common Mistakes in Dermatology Journal Selection
Sending basic science to JAAD. JAAD is clinically oriented. If your paper doesn't have direct clinical relevance, JAAD editors won't engage with it. Send mechanism-focused work to JID or Experimental Dermatology.
Ignoring subspecialty journals. Pediatric Dermatology, Dermatologic Surgery, and Contact Dermatitis exist for a reason. Subspecialty journals offer targeted readership that generalist journals can't match.
Overlooking the BJD transition. Since BJD went fully OA, the APC is now mandatory. Factor this into your budget before submitting.
Submitting images without proper quality. Dermatology is a visual specialty. Low-resolution clinical photos will get your paper desk-rejected at image-heavy journals like JAAD.
Not reviewing author guidelines for image formatting. Each journal has specific requirements for clinical photographs, histopathology images, and dermoscopic images. These aren't suggestions.
What We See In Dermatology Journal-Fit Reviews
In our pre-submission review work on dermatology manuscripts, the strongest journal-fit mistakes usually come from treating dermatology as one audience. Dermatology papers split quickly into clinician-facing, image-heavy, procedural, molecular, disease-specific, and open-access routes. A manuscript can be a good dermatology paper and still be aimed at the wrong dermatology journal.
Clinical studies without a clinical decision. JAMA Dermatology, JAAD, BJD, and JEADV are not just looking for skin-disease data. The abstract needs to show what a dermatologist, guideline author, or health-system reader can do differently. A cohort that only reports associations may be stronger at Clinical and Experimental Dermatology, Dermatology, or a disease-specific title unless the endpoint changes care.
Basic skin biology framed as clinical dermatology. Keratinocyte biology, immunology, wound healing, melanoma mechanism, or genetic skin-disease work needs the mechanism-to-disease bridge. If the figures prove a pathway but the discussion does not explain clinical or translational relevance, JID, JID Innovations, or Experimental Dermatology is usually cleaner than JAAD.
Visual evidence treated as decoration. Dermatology reviewers notice image quality immediately. Clinical photographs, dermoscopy, histopathology, and before/after procedural images need consistent lighting, labeling, consent language, and figure logic. Weak images can make a clinically useful study look unserious before the statistics are read.
The practical check we use is to name the manuscript's main reader before naming the journal. If the reader is a dermatologist changing patient management, a clinician-facing route makes sense. If the reader is a skin-biologist testing mechanism, a JID-family or experimental route is cleaner. If the reader is a procedural specialist, Dermatologic Surgery is not a fallback; it is often the correct first audience.
Submit If / Think Twice If
Submit if: the manuscript's first proof object matches the journal's reader: a practice implication for JAAD or JAMA Dermatology, a disease-relevant mechanism for JID, a strong international clinical story for BJD or JEADV, a procedural outcome for Dermatologic Surgery, or an accessible clinical route for JAAD International, Acta Dermato-Venereologica, or CED.
Think twice if: the target is chosen mainly by headline metric, the paper needs a specialist audience, the clinical photos are not publication-ready, the mechanism is not tied to skin disease, or the open-access route is not funded. In those cases, a narrower dermatology journal often produces a better outcome than forcing the paper into a flagship screen.
Polish Your Paper Before Submitting
Dermatology journals are visual, detailed, and demanding. Before submitting, run your manuscript through manuscript readiness check to check for structural issues, statistical concerns, and formatting problems that could trigger a desk rejection. A few minutes of automated review can save you weeks of waiting for feedback you could have anticipated.
How to choose from this list
- Match scope precisely. A dermatology paper on clinical outcomes fits different journals than one on mechanisms.
- Check your constraints. Funder OA mandates, APC budgets, and timeline requirements narrow the list.
- Prioritize your audience. The best journal is where your citing researchers actually read.
- Be realistic about selectivity. If acceptance is <10%, have a backup identified.
Frequently asked questions
Journal of the American Academy of Dermatology (JAAD) is the most influential clinical dermatology journal with an IF around 11.5. For research-heavy manuscripts, Journal of Investigative Dermatology (JID, IF ~5.7) is the top choice. JAMA Dermatology (IF ~10.9) carries the weight of the JAMA brand.
In dermatology, an IF above 7 is excellent, 3-7 is strong, and 1.5-3 is respectable. The specialty is mid-sized, so IFs tend to be lower than cardiology or oncology but higher than many surgical subspecialties.
Yes. JAAD International, JID Innovations, and the British Journal of Dermatology (now OA) are all reputable. Check for society affiliation and PubMed indexing as quality indicators.
No. Clinical papers usually fit JAAD, JAMA Dermatology, BJD, JEADV, or CED, while skin-biology and mechanism papers usually fit JID, JID Innovations, or Experimental Dermatology. Match the journal to the reader who can use or evaluate the evidence.
Sources
Final step
Run the scan before you spend more on editing or external review.
Use the Free Readiness Scan to get a manuscript-specific signal on readiness, fit, figures, and citation risk before choosing the next paid service.
Best for commercial comparison pages where the buyer is still choosing the right help.
Anthropic Privacy Partner. Your manuscript is never used to train any model.